Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis  by Bassiouny, Hisham S. et al.
Juxtalumenal ocation of plaque necrosis 
and neoformation in symptomatic 
carotid stenosis 
Hisharn  S. Bass iotmy,  MD,  Yashuh i ro  Sakaguch i ,  MD,  
Susanne A. M ikuck i ,  MD,  PhD,  James F. McK insey ,  MD,  
G iancar lo  P iano ,  MD,  Bruce L. Gewer tz ,  MD,  and Seymour  G lagov ,  MD,  
Chicago, Ill. 
Purpose: The structural features that underlie carotid plaque disruption and symptoms 
are largely unknown. We have previously shown that the chemical composit ion and 
structural complexity of  critical carotid stenoses are related to plaque size regardless of  
symptoms. To further determine whether the spatial distr ibution of  individual plaque 
components in relation to the lumen corresponds to symptomatic outcome, we evaluated 
99 carotid endarterectomy plaques. 
Methods: Indications for operation were symptomatic disease in 59 instances (including 
hemispheric transient ischemic attack in 29, stroke in 19, and amaurosis fugax in 11) and 
angiographic asymptomatic stenosis > 75% in 40. Plaques removed after remote symp- 
toms beyond 6 months were excluded. Histologic sections from the most stenotic region 
of  the plaque were examined using computer-assisted morphometr ic analysis. The per- 
cent area of  plaque cross-section occupied by necrotic l ipid core with or without associ- 
ated plaque hematoma, by calcification, as well as the distance from the lumen or fibrous 
cap of  each of  these features, were determined. The presence of  foam cells, macrophages, 
and inflammatory cell collections within, on, or just beneath the fibrous cap was taken as 
an additional indication of  plaque neoformation. 
Results: The mean percent angiographic stenosis was 82% _+ 11% and 79% - 13% for the 
asymptomatic and symptomatic groups, respectively (p > 0.05). The necrotic core was 
twice as close to the lumen in symptomatic plaques when compared with asymptomatic 
plaques (0.27 + 0.3 mm vs 0.5 - 0.5 mm; p < 0.01). The percent area of  necrotic ore or 
calcification was similar for both groups (22% vs 26% and 7% vs 6%, respectively). There 
was no significant relationship to symptom production of  either the distance of  calcifica- 
t ion from the lumen or of  the percent area occupied by the l ipid necrotic core or 
calcification. The number of  macrophages infiltrating the region of  the fibrous cap was 
three times greater in the symptomatic plaques compared with the asymptomatic plaques 
(1114 -_. 1104 vs 385 -- 622, respectively, p < 0.009). Regions of fibrous cap disruption 
or ulceration were more commonly observed in the symptomatic plaques than in the 
asymptomatic plaques (32% vs 20%). None of  the demographic or clinical atherosclerosis 
risk factors distinguished between symptomatic and asymptomatic plaques. 
Conclusions: These findings indicate that proximity of  plaque necrotic ore to the lumen 
and cellular indicators of  plaque neOformation or inflammatory reaction about the 
fibrous cap are associated with clinical ischemic events. The morphologic omplexity of  
carotid stenoses does not  appear to determine symptomatic outcome but rather the 
topography of  individual plaque components in relation to the fibrous cap and the lumen. 
Imaging techniques that precisely resolve the posit ion of  the necrotic ore and evidence of  
inflammatory reactions within carotid plaques should help identify high-risk stenoses 
before disruption and symptomatic carotid disease. (J Vase Surg 1997;26:585-94.) 
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Table I. Clinical data (n = 99) 
All patients Symptomatic Asymptomatic p 
Patient number 
Male:female 
Age (yr) 
Symptoms 
Intervals (wk)* 
Diabetes mellitus 
Hypertension 
Hypercholesterolemia 
Smoking 
Coronary artery disease 
59 40 NS 
58:41 36:23 22:18 NS 
71-+8 70-+8 71- -9  NS 
TIA: 40 cases 
Stroke: 19 cases 
7_+11 
28 17 11 NS 
78 46 32 NS 
10 6 4 NS 
64 42 22 NS 
38 25 13 NS 
*Interval from symptom to operation. 
Atherosclerotic plaque disruption is recognized 
as a salient feature critical to the development of 
clinical ischemic manifestations i  both the coronary 
and carotid circulations. >s Although the structural 
features of advanced atherosclerotic plaques as well 
as the biomechanical forces imposed on them have 
been extensively studied, the relevance of particular 
plaque morphologic features to fibrous cap erosion 
and plaque complications such as thrombosis, embo- 
lization, and intraplaque hematoma has yet to be 
elucidated. We have previously demonstrated that 
symptomatic and asymptomatic critical carotid ste- 
nosis have similar morphologic and chemical fea- 
tures. Morphologic omplexity was related to plaque 
size regardless of symptoms. 6 Conversely, other in- 
vestigators have observed that carotid artery plaques 
in symptomatic patients contained more soft choles- 
terol amorphous debris and hemorrhage and less 
collagenous material when compared with asymp- 
tomatic patients. 7,8 A recognized limitation inherent 
to the aforementioned studies is the lack of precise 
quantitation of the individual components of the 
plaque and inconsistencies with regard to the se- 
lected sampling site. 
More recently, the role of inflammatory cell infil- 
trate has been invoked in unstable, symptom-pro- 
ducing carotid and coronary plaques 9 1~ and related 
to degradation fthe fibrous cap and plaque neofor- 
marion. A variety of biomechanical f ctors have also 
been postulated to play a role in plaque disruption. 
These include mechanical stresses associated with 
hemodynamic wall shear or pressure fluctua- 
lions) 2qs Although advanced symptomatic and 
asymptomatic carotid plaques contain similar fi- 
brous, necrotic, and calcific components, we postu- 
lated that the spatial distribution of these individual 
components in relation to the lumen and the xtent 
of inflammatory cell infiltration, and in particular 
macrophage foam cell connoting plaque neoforma- 
tion in thc abluminal fibrous cap, could discriminate 
between symptomatic and asymptomatic outcome. 
We therefore xamined a large number of symptom- 
atic and asymptomatic carotid plaques with similar 
degrees of stenosis that had been removed at endar- 
terectomy. In view of the relationship between 
plaque complexity, that is, the presence of a diversity 
of plaque components and plaque size or degree of 
stenosis, we evaluated histologic sections from the 
most stenotic region of these plaques with respect to 
the relative quantity and location of the various 
plaque components and the proximity of these ele- 
ments to each other and the lumen surface. We 
further measured the degree of macrophage infiltra- 
tion in and about the fibrous cap as a measure of 
likely plaque neoformation. This investigation al- 
lowed for a more objective comparative analysis of 
the notable morphologic features in endarterecto- 
mized symptomatic nd asymptomatic plaques. 
MATERIALS AND METHODS 
Carotid endarterectomy specimens. Speci- 
mens were obtained from 99 patients (58 men and 
41 women) who underwent carotid endarterectomy 
for treatment of high-grade carotid stenosis. The 
patients' mean age was 71 years, with a range of 48 
to 90 years. Ninety-six patients had undergone uni- 
lateral carotid endarterectomy, and three had under- 
gone bilateral carotid endarterectomy. In all patients, 
aortic arch and four-vessel arteriography was per- 
formed before surgery, and lumen stenosis was calcu- 
lated from diameter measurements at the stenosis 
and at the nonstenotic distal internal carotid artery. 
Clinical risk factors for atherosclerosis were recorded 
for all patients. 
Carotid endarterectomy was performed for symp- 
tomatic arotid isease in 59 instances. Forty patients 
had had atransient ischemic attack within 20 weeks 
before the operation, 19 patients had had a stroke 
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more than 1 month before the operation. In 40 
instances, endarterectomy was performed for high- 
grade asymptomatic carotid stenosis (Table I). 
Plaques were endarterectomized using a standard 
open technique to minimize histopathologic arti- 
facts. The harvested specimen included plaque in- 
volving file distal common carotid artery in continu- 
ity with the bifurcation and its extension into the 
internal and external carotid arteries. Morphologic 
evaluation of the harvested plaques was conducted 
by an experienced angiopathologist (S.G.) and were 
carefully scrutinized for disruptions related to opera- 
tiv c manipulation. The depth of the arteriotomy was 
limited to the outer media whenever technically fea- 
sible to minimize disruption of the luminal surface at 
the regions of greatest plaque burden. The arteriot- 
omy was uniformly carried into the lumen of the 
internal carotid artery to adequately visualize the 
plaque's terminal endpoint. 
The fresh endarterectomy specimen was rinsed 
gently in normal saline solution to remove surface 
blood; inspected for macroscopic evidence of hemor- 
rhage, ulceration, and thrombosis; and then photo- 
graphed. Each specimen was immersed in 10% for- 
malin fixative and subsequently in a decalcifying 
solution. The specimens were sectioned perpendicu- 
lar to the axial centerline of the common and internal 
carotid artery segments at 0.5 cm intervals, and the 
blocks were numbered in sequence as shown in 
Fig. 1. For most of the specimens. Seven to eight 
blocks were available. Each block was processed 
through paraffin, sectioned at 5 ~tm, and stained 
with hematoxylin and eosin and by the Gomori 
trichrome aldehyde fucshin and Weigert von 
Gieson procedures for distinguishing connective 
tissue fibers and cells. 
Sections were examined to characterize the fol- 
lowing histologic features at each level: necrosis, cal- 
cification, fibrous cap erosion or ulceration, hemor- 
rhage, thrombosis, and evidence of macrophage and 
inflammatory cell reactions about the fibrous cap. 
Sections at each level contained characteristic fea- 
tures of plaque composition, but these were most 
abundant and varied at the level of the largest plaque. 
The maximum plaque area often corresponded to
the level of maximum cross-sectional stenosis as de- 
termined by morphometric analysis and usually oc- 
curred in the proximal region of the sinus. Although 
the principle findings reported here were similar at all 
levels, they were most striking at the level with the 
largest plaque regardless of absolute degree of steno- 
sis. The present report herefore deals with the mor- 
phometric findings in the sections with the largest 
Fig. 1. Diagram of section levels in carotid bifurcation 
specimens. 
plaque area of each endarterectomy specimen. Spe- 
cial plaque morphologic features and complexity at 
each level with respect to distance from the bifurca- 
tion will be addressed in future studies. 
Morphometric analysis of plaque compo- 
nents. The selected sections were photographed 
and used to produce magnified (x22) color prints. 
Contours of the lumen, internal elastic lamina, fi- 
brous cap, regions of necrosis, and calcification were 
traced on the prints, and dimensions were computed 
by using on-line computer-assisted program. 
The fibrous cap was defined as the immediate 
subendothelial region and usually consisted of a 
compact layer of smooth muscle cells and connective 
tissue fibers. More extensive fibrous zones without 
clear demarcation  the selected sections were mea- 
sured on the basis of estimates made from views of 
adjacent sections. The necrotic ore usually occupied 
deeper egions of the plaque and was composed of 
amorphous debris and cholesterol c efts. Distinct cal- 
cific deposits appeared as dark blue, sharply demar- 
cated regions in the hematoxylin and eosin stains. 
Fine punctate calcific deposits often occurred in asso- 
ciation with myxomatous regions. These were not 
quantitated for the present study. 
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Fig. 2. Illustration represents computer-assisted morphometric analysis of plaque cross-sec- 
tions. As shown, individual plaque components were contour-traced and distance between each 
component and fibrous cap and lumen were measured. Distance between ecrotic ore and 
fibrous cap or lumen is represented bya and b. Distance between calcification and fibrous cap or 
lumen is represented byc and d. 
The absolute area of each component was com- 
puted from the contour tracings. In addition, the 
percent area of each component was calculated using 
the following formula: percent area = (area of a 
component/total  rea of plaque section ) × 100. 
The shortest distance from the necrotic core and 
calcification regions of the lumen or fibrous cap and 
the minimum thickness of the fibrous cap overlying 
the necrotic ore were also measured (Fig. 2). 
Measurement o f  presumed plaque neoforma- 
tion; macrophage infiltration. Because foam cells 
of macrophage origin are associated with early 
plaque evolution and necrotic core formation, we 
determined the number of macrophages in and 
about the fibrous caps of 45 of the asymptomatic 
(n = 22) and symptomatic (n = 2i )  sections. Immu- 
nohistochemical staining for macrophages was car- 
fled out on paratfin-embedded sections mounted on 
poly-L-lysin-coated slides and air dried overnight. 
Sections were deparafinized by immersing the slides 
in two changes of xylene for 15 minutes each and 
then rehydrated in 100%, 95%, and 75% ethanol for 3 
minutes each. After rehydration, sections were 
washed in phosphate-buffered saline solution. En- 
dogenous peroxidase activity was blocked with 3.0% 
hydrogen peroxide (H202) in phosphate-buffered 
saline solution. Sections were pretreated with 10% 
goat serum for 20 minutes and then incubated with 
mouse antihuman macrophage ntibody (i :30 dilu- 
tion) for 1 hour at 37 ° C. The avidin-biotin-immu- 
noperoxidase method was used to identify the mac- 
rophages according to the supplier's guidelines 
(Vector, Calif.). Incubation with 0.1% 3',3'-diami- 
nobezidine and H202 at room temperature for 5 to 
i 0 minutes produced abrown reaction product. Sec- 
tions were lightly counterstained with hematoxylin 
to visualize nuclei. The number of macrophages was 
counted in five successive sections in the region of 
the plaque with largest area. The total number of 
macrophages per unit area was determined in the 
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Fig. 3. Photomicrograph ofa histologic section (original magnification, ×25) in a symptom- 
atic plaque representing fibrous cap thinning and erosion with exposure ofthe necrotic core to
the lumen. 
fibrous cap regions overlying the necrotic core. 
These were identified as the regions of  the plaque 
between the necrotic ore and lumen composed 
characteristically of  smooth muscle cells, extracellular 
matrix, and connective tissue fibers. 
Statistical analysis. Results were expressed as 
mean _+ SD. All morphometric data and cellular 
counts of macrophage infiltration were compared 
between asymptomatic and symptomatic plaques us- 
ing paired Student's t tests. X 2 analysis was used to 
compare clinical demographics between both 
groups. Differences were considered significant at the 
p < 0.05 level. 
RESULTS 
Clinical featttres and risk factors. Patients who 
underwent eudarterectomy for symptomatic carotid 
atherosclerosis or asymptomatic severe carotid steno- 
ses had similar clinical findings (Table I). Although a 
trend toward greater exposure to atherosclerosis r k 
factors was noted in symptomatic patients compared 
with asymptomatic patients, the differences were not 
statistically significant. 
Histopathologic analysis. Sections of large 
plaques from both symptomatic and asymptomatic 
patients exhibited microanatomic complexity. These 
included the presence of necrotic and calcific regions 
with an overlying fibrous cap or fibrous regions of 
varied thickness. Histopathologic features associated 
with plaque disruption, notably ulceration, plaque 
hematoma, fresh surface thrombosis, and inflamma- 
tion, were observed. Regions of actual fibrous cap 
disruption or ulceration were observed in 32% of 
specimens associated with symptoms (19 of  59) and 
in only 20% of those without symptoms (eight of 
40). The prevalence of  recent intraplaque hematoma 
and surface thrombosis was not different between 
symptomatic and asymptomatic plaques (19% and 8% 
vs 18% and 5%, respectively). Fig. 3 is representative 
of  a symptomatic plaque. There is fibrous cap erosion 
with exposure of the underlying necrotic ore to the 
lumen. Fig. 4 is from a section of  an asymptomatic 
plaque. A thick fibrous cap overlies and isolates the 
necrotic ore from the lumen. 
Morphometr ic  analysis. The mean plaque area 
of all specimens was 35 + 12 mm 2 (range, 13 to 65). 
Mean percent cross-sectional stenosis was 81% + 
12% (range, 42% to 99%). The mean percent necrotic 
core area was 21% + 18% (range, 0% to 77%), and the 
mean percent calcification area was 7.0% -+ 11% 
(range, 0.4% to 40%). The mean percent stenosis was 
79% + 13% (range, 54% to 99%) in symptomatic 
plaques and 82% + 11% (range, 42% to 99%) in 
asymptomatic plaques (p > 0.05, NS). 
The mean percent area of  necrotic core and of  
calcification were not significantly different in symp- 
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Fig. 4. Photomicrograph (original magnification ×15) illustrates well-developed fibrous cap 
isolating plaque necrotic core from lumen in asymptomatic plaque. 
Table I I .  Plaque component area 
All patients Symptomatic Asymptomatic 
& = 99) (n = 59) (n = 40) p 
Plaque area (mm 2) 35% _+ 12% 35% _+ 11% 35% -+ 13% NS 
Percent stenosis 81% +_ 12% 79% -+ 13% 82% -+ 11% NS 
Percent necrotic ore 21% + 18% 22% _+ 16% 26% +- 18% NS 
Percent calcification 7% _+ 11% 7% _+ 10% 6% -+ 10% NS 
Percent fibrous cap 10% + 6% 11% _+ 6% 10% _+ 6% NS 
Values expressed as mean _+ SD of mean. 
tomatic and asymptomatic plaques. Values were 22% 
_+ 16% vs 26% + 18% and 7% + 10% vs 6% +_ 10%, 
respectively. Similarly, the mean percent fibrous cap 
area was not different for symptomatic and asymp- 
tomatic plaques (11% + 6% vs 10% + 6%, respec- 
tively; Table II). 
Distance between major  plaque components  
and fibrous cap or lumen. For all of  the sections, 
the mean distance between ecrotic core and fibrous 
cap was 0.2 -+ 0.3 mm (range, 0 to 1.2 mm; Table 
I I I).  The distance between the necrotic core and the 
lumen was 0.4 + 0.7 mm (range, 0 to 1.4 mm). The 
mcan distance between thc calcification and the fi- 
brous cap was 0.5 _+ 0.9 mm (range, 0 to 4.4 mm); 
the mean distance between the calcification and the 
lumen was 0.8 + 1.0 mm (range, 0 to 5.4 mm). The 
mean distance between the necrotic core and the 
fibrous cap was significantly less in symptomatic 
plaques when compared with asymptomatic plaques 
(0.05 + 0.2 mm vs 0.20 -+ 0.3 mm; p < 0.01). A 
scattergram of these values is represented in Fig. 5, 
A. The necrotic core was twice as close to the lumen 
in symptomatic plaques (0.27 _+ 0.3 mm) compared 
with asymptomatic plaques (0.50 -+ 0.5 mm; p < 
0.01). A scattergram of these values is represented in 
Fig. 5, B. The mean distance between the calcifica- 
tion and the fibrous cap was 0.55 + 1.1 mm (range, 
0 to 4.4 mm) in symptomatic plaques and 0.05 _+ 0.3 
mm (range, 0 to 3.4 mm) in asymptomatic plaques. 
The mean distance between the calcification and the 
lumen was 0.78 -+ 1.0 mm (range, 0 to 5.3 mm) and 
0.27 -+ 1.0 mm (range; 0 to 5.3 mm) in symptomatic 
and asymptomatic plaques, respectively. Differences 
for calcification localization were not significant. The 
minimum thickness of the fibrous cap was measured 
in the plaque sections that were used for macrophage 
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Fig. 5. Scattergram represents values of the distance between the necrotic ore and the fibrous 
cap (A) and the lumen (B). 
Table I I I .  Distance of plaque components from fibrous cap and lumen 
All patients Symptomatic Asymptomatic 
(n = 99) (n = 59) (n = 40) p 
N1 (ram 0.2 -+ 0.3 0.05 + 0.2 0.20 + 0.3 0.01 
N2 (ram) 0.4 + 0.7 0.27 + 0.3 0.50 -+ 0.5 0.01 
C1 (mm) 0.5 _+ 0.9 0.55 _+ 1.1 0.05 _+ 0.3 NS 
C2 (mm) 0.8 _+ 1.0 0.78 _+ 1.3 0.27 _+ 1.0 NS 
N1, Distance between necrotic ore and fibrous cap; N2, distance between necrotic core and lumen; CI, distance between calcification and 
fibrous cap; C2, distance between calcification and lumen. 
Values expressed asmean _+ SD. 
characterization. The minimum fibrous cap thicl~aess 
was significantly less for the symptomatic plaques 
(0.2 + 0.2 ram) compared with asymptomatic 
plaques (0.4 _+ 0.4 ram; p < 0.006). 
Macrophage infiltration. The number of mac- 
rophages infiltrating the region of the fibrous mate- 
rial overlying the necrotic core was significantly 
greater in symptomatic plaques compared with 
asymptomatic plaques (1144 + 1104 vs 385 + 622, 
respectively; p < 0.009). Fig. 6 depicts macrophage 
infiltration in the fibrous cap region. 
DISCUSSION 
The mechanisms that underlie plaque instability 
may involve biologic factors that are intrinsic to 
plaque structure and biomechanical factors that in- 
duce structural breakdown or specific cellular re- 
sponses. The purpose of this study was to further 
define and quantitate individual structural compo- 
nents at the level of  largest plaque burden of symp- 
tomatic and asymptomatic carotid bifurcation endar- 
terectomy specimens and to determine their spatial 
distribution in relation to the fibrous cap and lumen. 
The rationale for this analysis was to asses whether 
predominantly necrotic or calcific plaques were more 
closely associated with symptoms or whether the 
position of these components in relation to the fi- 
brous cap and lumen were more important determi- 
nants of clinical outcome. We also investigated the 
association between presumed plaque neoformation, 
as represented by macrophage infiltration in and 
about the fibrous cap, and fibrous cap thinning and 
cerebral ischemic events. 
We found that large symptomatic and asymptom- 
atic plaques, often highly stenotic, possess remark- 
ably similar histopathologic features with regard to 
the presence of necrosis, calcification, fibrous cap 
ulceration, hemorrhage, and surface thrombosis. Al- 
though intraplaque hemorrhage hematoma nd sur- 
face thrombosis have been regarded by other investi- 
gators as cardinal features of symptomatic plaques, 17 
such a finding is not substantiated in the current 
study. This may be related in part to the variable 
interval between histologic examination of the end- 
arterectomy specimen and neurologic symptoms. 
These observations substantiate our previous find- 
ings 6 regarding the morphologic and chemical simi- 
larity between symptomatic and asymptomatic criti- 
cal stcnoses) 1 Several new findings have, however, 
emerged from this current analysis that help to iden- 
tify structural features associated with plaque disrup- 
tion and symptoms. 
It is evident from our findings that the proximity 
of the necrotic core to the overlying fibrous cap and 
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Fig. 6. Immunohistochemical staining of macrophages infiltrating the fibrous cap using 
mouse antihuman macrophage antibody (original magnification, × 50). 
lumen, rather than its absolute or percent cross- 
sectional area, is a striking feature of symptomatic 
plaques. In symptomatic plaques, the necrotic ore 
was twice as close to the lumen when compared with 
asymptomatic plaques, whereas the degree or loca- 
tion of calcification had little effect. Thus the spatial 
relationship among the matrix and necrotic ompo- 
nents appear to be most important in defining likely 
plaque stability than the content of these elements. 
These findings likely represent the dynamic equilib- 
rium that exists among factors that favor fibrogencsis 
versus those that induce matrix degradation. 16-21 
Symptomatic plaques also exhibited a greater de- 
gree of macrophage infiltration in and about the 
fibrous cap and were associated with fibrous cap 
thinning and erosion, implicating an ongoing induc- 
tion of plaque formation or an inflammatory or im- 
mune-mediated response as a factor in plaque insta- 
bility. Other investigators have also noted that 
ruptured plaques are infiltrated by foam cells, espe- 
cially in regions where the fibrous cap is thin- 
nest.2,3,10,11,22 
Foam cells derived from mononuclear phago- 
cytes in atherosclerotic plaques are known to elabo- 
rate a number of matrix metalloproteinases, such as 
interstitial collagenase, gelatinase, nd stromelysin, 
all of which are capable of degrading collagen, elas- 
tin, and proteocoglycans. 2a-27 Such processes could 
lead to thinning of the fibrous cap and disruption, 
particularly if potent mechanical stresses are present. 
We are currently investigating the contribution f 
macrophage infiltration and apoptosis to the relative 
activity of metalloproteinases and tissue inhibitors of 
metalloproteinases. Preliminary results indicate that 
the apoptotic rate is proportional to the number of 
infiltrating macrophages and is related to symptom- 
atic disease and to the position of the necrotic ore 
within the plaque. Macrophage infiltration and apo- 
ptosis may modulate l sion progression and necrosis 
by the release of injurious free radicals and other 
mitogenic and tissue necrosis factors. 2 -3° Activated 
macrophages may also induce a prothrombotic effect 
by inhibiting tissue plasminogcn activators and 
thereby enhancing the thrombotic complications a - 
sociated with complex atherosclerotic plaques. 32,33 
Our results also indicate that plaque complica- 
tions such as intraplaque hematoma nd surface 
thrombosis, although characteristic of large ad- 
vanced plaques, did not discriminate between symp- 
tomatic and asymptomatic plaques and appeared to 
represent events, probably as a result of plaque fissur- 
ing or rupture. 
The potential role of biomechanical forces in in- 
ducing structural fatigue of plaque constituents and 
the localization of plaque neoformation a d inflam- 
matory cell responses is under study. Marked eleva- 
tion of wall shear stress occurs within stenoscs that 
are associated with large plaques. Although high 
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shear may inhibit plaque formation, 34 changes in 
flow dynamics associated with marked stenoses, in- 
cluding wall vibration, flutter, and cyclical collapse, 3s 
could induce disruptions within plaques, lumen ulcer 
formation, and associated surface irregularities. Vito 
and others 36,37 have emphasized the relationship be- 
tween plaque composition and the location of peak 
stress. For example, it has been found that proximity 
of the necrotic core to the lumen increases the stress 
concentration in the overlying fibrous cap. Others 
have demonstrated an association between regions of 
macrophage infiltration and mechanical stress con- 
centration. 
The findings of this study suggest that a key 
associative vent in carotid plaque fibrous cap disrup- 
tion and symptoms are the reactions induced by 
macrophage or foam cell infiltration in the abluminal 
fibrous cap, as well as the proximity of the necrotic 
core to the lumen, which result in the thinning and 
eventual erosion of the fibrous cap. In vivo studies of 
the interactions between plaque composition and the 
corresponding flow and tensile-mechanical-associ- 
ated properties are warranted, especially when mor- 
phologic and mechanical properties may be studied 
in these same plaques removed at endarterectomy. 
Such detailed correlations could help identify these 
lesions and mechanical factors that render plaques 
susceptible to disruption and to the onset of symp- 
tomatic carotid artery disease. 
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